FDA Inspection 1232999 — Lions Eye Bank Of Nebraska
The FDA completed an inspection of Lions Eye Bank Of Nebraska on Feb 21, 2024 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 21, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Omaha, NE (United States)